| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $40K | — | +0.0% |
| R&D Expense | $1.3M | — | +28.9% |
| SG&A Expense | $489K | — | +262.3% |
| Operating Income | -$7.1M | — | +81.2% |
| Interest Expense | $983K | — | +218.1% |
| Net Income | -$8.8M | — | +76.8% |
| EPS (Basic) | -$0.38 | — | +81.9% |
| EPS (Diluted) | -$0.38 | — | +81.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $139K | +136.0% | -97.5% |
| Current Assets | $2.1M | +50.9% | -71.5% |
| Total Assets | $3.3M | +17.9% | -60.6% |
| Current Liabilities | $16.3M | -18.7% | -9.8% |
| Total Liabilities | $16.6M | -18.5% | — |
| Stockholders' Equity | -$13.2M | +24.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$7.0M | — | -23.7% |
| Financing Cash Flow | $7.1M | — | -35.9% |
| -37.5% |